Filing Details

Accession Number:
0000899243-21-000136
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-04 17:31:27
Reporting Period:
2020-12-30
Accepted Time:
2021-01-04 17:31:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1745999 Beam Therapeutics Inc. BEAM Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786304 M. John Evans C/O Beam Therapeutics Inc.
26 Landsdowne Street
Cambridge MA 02139
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-30 1,366 $81.14 991,891 No 4 S Direct
Common Stock Disposition 2020-12-30 4,100 $82.33 987,791 No 4 S Direct
Common Stock Disposition 2020-12-30 4,925 $83.76 982,866 No 4 S Direct
Common Stock Disposition 2020-12-30 1,422 $85.35 981,444 No 4 S Direct
Common Stock Disposition 2020-12-30 7,196 $86.21 974,248 No 4 S Direct
Common Stock Disposition 2020-12-30 504 $86.79 973,744 No 4 S Direct
Common Stock Disposition 2020-12-30 1,121 $88.12 972,623 No 4 S Direct
Common Stock Disposition 2020-12-30 1,666 $89.41 970,957 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 223,000 Indirect By John M. Evans, III 2018 Irrevocable Trust
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. These shares were sold in multiple transactions ranging from $81.00 to $81.46 inclusive.
  3. These shares were sold in multiple transactions ranging from $82.00 to $82.99 inclusive.
  4. These shares were sold in multiple transactions ranging from $83.19 to $84.07 inclusive.
  5. These shares were sold in multiple transactions ranging from $84.63 to $85.58 inclusive.
  6. These shares were sold in multiple transactions ranging from $85.63 to $86.60 inclusive.
  7. These shares were sold in multiple transactions ranging from $86.65 to $86.97 inclusive.
  8. These shares were sold in multiple transactions ranging from $87.96 to $88.50 inclusive.
  9. These shares were sold in multiple transactions ranging from $89.00 to $89.66 inclusive.